DURECT

$0.00 (0.00%) As of 1:10 PM UTC pre-market

Why Robinhood?

You can buy or sell DURECT and other stocks, options, and ETFs commission-free!

About DRRX

DURECT Corp. focuses in advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator.

CEO
James E. Brown
Employees
81
Headquarters
Cupertino, California
Founded
1998

DRRX Key Statistics

Market Cap
397.96M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
585.51K
High Today
$1.80
Low Today
$1.71
Open Price
$1.78
Volume
544.64K
52 Week High
$2.95
52 Week Low
$1.52

DRRX Earnings

-$0.05
-$0.01
$0.03
$0.07
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 2, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure